Search research articles
Contact Us
Filters
Showing results (61-70 of 136) with videos related to
Page
of 14
Sort By:
Annals of Surgical Oncology
|
March 3, 2004
Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model
Vernon K Sondak, Jeremy M G Taylor, Michael S Sabel, et al.
Cancer
|
September 25, 2014
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933
Sylvia M Lee, James Moon, Bruce G Redman, et al.
Cancer
|
April 2, 2011
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430
Jeffrey A Sosman, James Moon, Ralph J Tuthill, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
October 8, 2011
Cardiovascular magnetic resonance activity in the United Kingdom: a survey on behalf of the British Society of Cardiovascular Magnetic Resonance
Renjith Antony, Marwa Daghem, Gerry P McCann, et al.
Cancers
|
May 13, 2023
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review
Islam Eljilany, Arish Noor, Mahati Paravathaneni, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
October 17, 2007
Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709
Amit Agrawal, James Moon, R Kim Davis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
Paul J Hesketh, Kari Chansky, Antoinette J Wozniak, et al.
Cancer
|
November 18, 2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508
Joseph I Clark, James Moon, Laura F Hutchins, et al.
Cancer
|
April 23, 2014
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)
Gerold Bepler, Ralph G Zinner, James Moon, et al.
Clinical Lung Cancer
|
November 10, 2021
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC
Fred R Hirsch, Mary W Redman, James Moon, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 136) with videos related to
Sort By:
Page
of 14
Annals of Surgical Oncology
|
March 3, 2004
Mitotic rate and younger age are predictors of sentinel lymph node positivity: lessons learned from the generation of a probabilistic model
Vernon K Sondak, Jeremy M G Taylor, Michael S Sabel, et al.
Cancer
|
September 25, 2014
Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933
Sylvia M Lee, James Moon, Bruce G Redman, et al.
Cancer
|
April 2, 2011
A phase 2 trial of complete resection for stage IV melanoma: results of Southwest Oncology Group Clinical Trial S9430
Jeffrey A Sosman, James Moon, Ralph J Tuthill, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance
|
October 8, 2011
Cardiovascular magnetic resonance activity in the United Kingdom: a survey on behalf of the British Society of Cardiovascular Magnetic Resonance
Renjith Antony, Marwa Daghem, Gerry P McCann, et al.
Cancers
|
May 13, 2023
Granulomatous and Sarcoid-like Immune-Related Adverse Events following CTLA4 and PD1 Blockade Adjuvant Therapy of Melanoma: A Combined Analysis of ECOG-ACRIN E1609 and SWOG S1404 Phase III Trials and a Literature Review
Islam Eljilany, Arish Noor, Mahati Paravathaneni, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
October 17, 2007
Transoral carbon dioxide laser supraglottic laryngectomy and irradiation in stage I, II, and III squamous cell carcinoma of the supraglottic larynx: report of Southwest Oncology Group Phase 2 Trial S9709
Amit Agrawal, James Moon, R Kim Davis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
September 2, 2008
Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2
Paul J Hesketh, Kari Chansky, Antoinette J Wozniak, et al.
Cancer
|
November 18, 2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508
Joseph I Clark, James Moon, Laura F Hutchins, et al.
Cancer
|
April 23, 2014
A phase 2 cooperative group adjuvant trial using a biomarker-based decision algorithm in patients with stage I non-small cell lung cancer (SWOG-0720, NCT00792701)
Gerold Bepler, Ralph G Zinner, James Moon, et al.
Clinical Lung Cancer
|
November 10, 2021
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC
Fred R Hirsch, Mary W Redman, James Moon, et al.
Page
of 14